Show simple item record

dc.contributor.authorZelkó, Romána*
dc.contributor.authorLamprou, Dimitrios A.*
dc.contributor.authorSebe, István*
dc.date.accessioned2021-02-12T01:06:01Z
dc.date.available2021-02-12T01:06:01Z
dc.date.issued2020*
dc.date.submitted2020-04-07 23:07:09*
dc.identifier44867*
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/57765
dc.description.abstractSeveral promising techniques have been developed to overcome the poor solubility and/or membrane permeability properties of new drug candidates, including different fiber formation methods. Electrospinning is one of the most commonly used spinning techniques for fiber formation, induced by the high voltage applied to the drug-loaded solution. With modifying the characteristics of the solution and the spinning parameters, the functionality-related properties of the formulated fibers can be finely tuned. The fiber properties (i.e., high specific surface area, porosity, and the possibility of controlling the crystalline–amorphous phase transitions of the loaded drugs) enable the improved rate and extent of solubility, causing a rapid onset of absorption. However, the enhanced molecular mobility of the amorphous drugs embedded into the fibers is also responsible for their physical–chemical instability. This Special Issue will address new developments in the area of electrospun nanofibers for drug delivery and wound healing applications, covering recent advantages and future directions in electrospun fiber formulations and scalability. Moreover, it serves to highlight and capture the contemporary progress in electrospinning techniques, with particular attention to the industrial feasibility of developing pharmaceutical dosage forms. All aspects of small molecule or biologics-loaded fibrous dosage forms, focusing on the processability, structures and functions, and stability issues, are included.*
dc.languageEnglish*
dc.subjectR5-920*
dc.subjectRM1-950*
dc.subject.classificationbic Book Industry Communication::M Medicineen_US
dc.subject.otherantibacterial activity*
dc.subject.otherpiroxicam*
dc.subject.othern/a*
dc.subject.othertissue engineering*
dc.subject.otherbiotechnology*
dc.subject.otherpolydextrose*
dc.subject.othersolvent casting*
dc.subject.otherantibacterial*
dc.subject.otherdrug delivery*
dc.subject.otherdiabetic*
dc.subject.otherpectin*
dc.subject.othernanotechnology*
dc.subject.othernanocomposite*
dc.subject.otherhydroxypropyl methyl cellulose*
dc.subject.otherpoorly water-soluble drug*
dc.subject.otherartificial red blood cells*
dc.subject.otheroral dosage form*
dc.subject.otherLactobacillus*
dc.subject.otherscanning electron microscopy*
dc.subject.otherwound healing*
dc.subject.otherUV imaging*
dc.subject.otherwetting*
dc.subject.otherbiocompatibility*
dc.subject.otherscale-up*
dc.subject.otherpolylactide-co-polycaprolactone*
dc.subject.othernanofibers*
dc.subject.othergrowth factor*
dc.subject.otherdrug release kinetics*
dc.subject.otherhydrogel*
dc.subject.otherdifferential scanning calorimetry*
dc.subject.otherbacterial bioreporters*
dc.subject.otherphysical solid-state properties*
dc.subject.otherPCL*
dc.subject.othercoaxial spinning*
dc.subject.otherdrug delivery system*
dc.subject.otherhaemanthamine*
dc.subject.otherprobiotics*
dc.subject.otheramphiphilic nanofibers*
dc.subject.otherwound dressings*
dc.subject.othergrinding*
dc.subject.otherscanning white light interferometry*
dc.subject.otherbiopharmaceuticals*
dc.subject.otherclove essential oil*
dc.subject.otherviability*
dc.subject.otherplant-origin alkaloid*
dc.subject.otheroligochitosan*
dc.subject.otherlocal delivery*
dc.subject.otherelectrospinning*
dc.subject.otherLactococcus*
dc.subject.otherself-assembled liposomes*
dc.subject.othermicrocapsules*
dc.subject.othermicrofibers*
dc.subject.othernanofiber*
dc.subject.otherin situ drug release*
dc.subject.otherbiomedical*
dc.subject.othercore-sheath nanofibers*
dc.subject.otherprocessability*
dc.subject.otherpolymeric carrier*
dc.subject.otheraceclofenac*
dc.subject.otherdrying*
dc.subject.othergentamicin sulfate*
dc.subject.othertraditional electrospinning*
dc.subject.otherelectrospinning and electrospray*
dc.subject.otherfourier transform infrared spectroscopy*
dc.subject.otherdrug release*
dc.subject.othergelatin*
dc.subject.otherultrasound-enhanced electrospinning*
dc.subject.other3D printing*
dc.titleRecent Development of Electrospinning for Drug Delivery*
dc.typebook
oapen.identifier.doi10.3390/books978-3-03928-141-1*
oapen.relation.isPublishedBy46cabcaa-dd94-4bfe-87b4-55023c1b36d0*
oapen.relation.isbn9783039281411*
oapen.relation.isbn9783039281404*
oapen.pages206*
oapen.edition1st*


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by-nc-nd/4.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc-nd/4.0/